Rebecca Abigail Berman, MD
Internal Medicine · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 2
- Since medical school
- 21 years
- Harvard Medical School, 2005
Offices
2 locations · University of California San Francisco · University of California Sfgh Medical Group
Hospitals listed: UCSF Medical Center · Zuckerberg San Francisco General Hosp & Trauma Ctr. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Berman’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 91.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
- Zuckerberg San Francisco General Hosp & Trauma CtrSan Francisco, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of San Francisco Health Network, which runs 2 hospitalsPatients rate it 3 of 5 · 72% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.449, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.37, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.538, Oct 2024 – Sep 2025
See every measure and the patient survey for UCSF Medical Center
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.9 (3.79 to 6.02) · 7,590 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.8 (11.3 to 14.4) · 2,019 cases | Worse | Jan 2024 – Dec 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.4 (110.22 to 168.58) · 452 cases | Better | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.622 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.626 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.491 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,336 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.24 (0.58 to 1.9) · 4,689 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.89 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.1 · 132 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.6 · 454 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 618 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.7 · 5,000 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.22 (0.06 to 0.38) · 15,965 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.05 to 0.35) · 17,859 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.85 (0 to 1.83) · 4,184 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2 (1.1 to 2.9) · 6,516 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.35 (4.49 to 10.21) · 3,989 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5 (3.22 to 6.77) · 4,087 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.95 (0.74 to 3.15) · 2,034 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.95 (0.63 to 1.28) · 15,431 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 399 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.899 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.689 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.224 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16 · 156 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20 · 564 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 60.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.7 · 550 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 44.1 · 660 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 667 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (4.8 to 6.7) · 2,019 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6 · 421 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.5 · 53 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20 · 107 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (11.3 to 17.1) · 3,247 cases | No different | Jan 2022 – Dec 2024 |
What patients said (3,181 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 71% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 50% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Zuckerberg San Francisco General Hosp & Trauma Ctr
Behind the star rating — Deaths: 1 better, 6 the same, 0 worse of 7 measures. Safety: 1 better, 5 the same, 1 worse of 7 measures. Readmissions: 0 better, 7 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.449 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.37 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.538 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.9 (0 to 1.91) · 667 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.12 (0.76 to 1.49) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 195.34 (147.34 to 243.34) · 76 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.2 · 114 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.2 · 48 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 7.5 · 201 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.5 · 214 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.3 · 261 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 1,351 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.29 (0.07 to 0.5) · 4,709 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.39 (0.19 to 0.59) · 4,644 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.34 (2.11 to 6.56) · 795 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.59 (0 to 3.28) · 234 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.85 (1.33 to 4.38) · 861 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.95 (0.25 to 17.64) · 261 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6 (2.01 to 9.98) · 242 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.17 to 3.14) · 167 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.79 (0.08 to 1.49) · 4,129 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.4 · 35 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0.709 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.769 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 41 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 227 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 28.6 · 257 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 75.1 · 239 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.2 · 232 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 175 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.3 (8.3 to 15.1) · 175 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 37 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 132 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.6 (10.4 to 17.9) · 966 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.8 to 1.7) · 88 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,644 patients answered, 16% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 69% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 68% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 67% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 70% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 55% |
| "YES", patients would definitely recommend the hospital | 72% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$19,317
Medicare paid this office $19,317 for 90 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 45 | $5,857 | $78 |
| Long return visit (40+ min) | 35 | $4,802 | $104 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 50 | $1,362 | $15 |
| Short return visit (20+ min) | 14 | $882 | $52 |
Who their Medicare patients are
90 Original Medicare patients in 2024. Average age 75 · Women 59% · Also on Medicaid 48% · Health risk score 1.69. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 70% · Depression 32% · Diabetes 29% · Heart failure 28% · Chronic kidney disease 28% · Coronary heart disease 27% · Atrial fibrillation 21% · Cancer 19% · COPD 17% · Dementia 14% · Stroke 12%.
The office billed $127,050, Medicare allowed $26,656 and paid $19,317; for 295 services of 14 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 90 | 295 | 75 | 1.69 | $127,050 | $19,317 |
| 2023 | 97 | 260 | 71 | 1.78 | $141,838 | $22,956 |
| 2022 | 76 | 206 | 73 | 2.11 | $113,739 | $18,071 |
| 2021 | 79 | 226 | 71 | 1.37 | $111,043 | $17,987 |
| 2020 | 62 | 134 | 72 | 1.82 | $69,070 | $10,448 |
| 2019 | 63 | 166 | 70 | 1.65 | $78,175 | $12,277 |
| 2018 | 101 | 186 | 70 | 1.63 | $55,609 | $10,755 |
| 2017 | 193 | 390 | 69 | 1.50 | $113,764 | $23,055 |
| 2016 | 205 | 415 | 68 | 1.50 | $115,774 | $23,059 |
| 2015 | 159 | 327 | 69 | 1.59 | $89,261 | $18,251 |
| 2014 | 213 | 430 | 67 | 1.43 | $109,843 | $24,077 |
| 2013 | 128 | 193 | 66 | 1.32 | $45,984 | $10,461 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Long return visit (40+ min) | 33 | $5,891 | $111 |
| Return visit (30+ min) | 31 | $4,549 | $78 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $4,186 | $107 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $2,799 | $72 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $1,888 | $145 |
| Short return visit (20+ min) | 19 | $1,244 | $57 |
2022: 4 services
| Long return visit (40+ min) | 21 | $4,931 | $123 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $3,975 | $90 |
| Return visit (30+ min) | 30 | $3,446 | $72 |
| Short return visit (20+ min) | 16 | $1,071 | $60 |
2021: 4 services
| Return visit (30+ min) | 37 | $5,065 | $73 |
| Long return visit (40+ min) | 21 | $3,297 | $118 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $3,275 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $2,216 | $92 |
2020: 2 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 18 | $2,358 | $71 |
| Return visit (30+ min) | 23 | $2,141 | $63 |
2019: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $3,863 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $2,575 | $92 |
| Return visit (30+ min) | 21 | $1,715 | $64 |
| Hospital discharge day management, 30 minutes or less | 12 | $789 | $66 |
2018: 1 service
| Return visit (30+ min) | 79 | $6,034 | $54 |
2017: 3 services
| Return visit (30+ min) | 155 | $15,412 | $58 |
| Long return visit (40+ min) | 21 | $2,454 | $88 |
| Short return visit (20+ min) | 35 | $1,753 | $39 |
2016: 3 services
| Return visit (30+ min) | 145 | $14,950 | $57 |
| Long return visit (40+ min) | 24 | $2,723 | $78 |
| Short return visit (20+ min) | 57 | $2,161 | $32 |
2015: 3 services
| Return visit (30+ min) | 121 | $11,239 | $55 |
| Long return visit (40+ min) | 17 | $1,625 | $81 |
| Short return visit (20+ min) | 28 | $1,043 | $35 |
2014: 3 services
| Return visit (30+ min) | 146 | $14,218 | $57 |
| Short return visit (20+ min) | 72 | $3,078 | $36 |
| Long return visit (40+ min) | 22 | $2,002 | $87 |
2013: 2 services
| Return visit (30+ min) | 87 | $7,471 | $57 |
| Short return visit (20+ min) | 49 | $2,068 | $39 |
Medicaid work
$758 in 2021
Medicaid paid $758 for 39 billed services this clinician did in 2021, up to 13 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 39 | $758 |
| 2021 | 39 | 1 | 13 | $758 |
| 2018 | 121 | 1 | 31 | $4,855 |
See the largest Medicaid services in earlier years
2018
| Return visit (30+ min) | 121 | $4,855 |
Drugs they prescribed that Part D paid
$27,532
Pharmacies billed $27,532 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
443 generic and fewer than 11 brand-name prescriptions · $27,532 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Synthroid | 12 | $599 | $50 |
| Gabapentin | 18 | $545 | $30 |
| Pravastatin | 18 | $362 | $20 |
| Omeprazole | 20 | $213 | $11 |
| Atorvastatin | 38 | $186 | $5 |
See all 9 drugs
| Synthroid | 12 | $599 | $50 |
| Gabapentin | 18 | $545 | $30 |
| Pravastatin | 18 | $362 | $20 |
| Omeprazole | 20 | $213 | $11 |
| Atorvastatin | 38 | $186 | $5 |
| Amlodipine Besylate | 30 | $118 | $4 |
| Sertraline | 20 | $97 | $5 |
| Levothyroxine | 16 | $87 | $5 |
| Lisinopril | 25 | $69 | $3 |
Year by year
| 2024 | 510 | 89 | None | None | $27,532 |
| 2023 | 515 | 77 | None | None | $68,198 |
| 2022 | 425 | 64 | None | None | $78,546 |
| 2021 | 382 | 64 | None | 20% | $38,240 |
| 2020 | 196 | 57 | None | 26% | $19,500 |
| 2019 | 181 | 67 | None | 21% | $18,527 |
| 2018 | 961 | 106 | 3% (28) | None | $78,241 |
| 2017 | 1,480 | 161 | 5% (72) | 17% | $123,605 |
| 2016 | 1,388 | 142 | 5% (68) | 19% | $99,217 |
| 2015 | 1,145 | 119 | 7% (80) | 21% | $88,051 |
| 2014 | 858 | 101 | 6% (55) | None | $77,641 |
| 2013 | 557 | 72 | 3% (19) | None | $45,561 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Ozempic | 11 | $11,062 | $1,006 |
| Eliquis | 12 | $9,481 | $790 |
| Gabapentin | 25 | $860 | $34 |
| Diclofenac | 14 | $747 | $53 |
| Atorvastatin | 26 | $735 | $28 |
| Amlodipine Besylate | 24 | $454 | $19 |
| Omeprazole | 12 | $369 | $31 |
| Lisinopril | 17 | $358 | $21 |
| Metformin | 13 | $306 | $24 |
| Levothyroxine | 15 | $224 | $15 |
| Pravastatin | 13 | $223 | $17 |
| Escitalopram | 16 | $106 | $7 |
2022: 9 drugs
| Breo Ellipta | 11 | $6,155 | $560 |
| Atorvastatin | 18 | $374 | $21 |
| Gabapentin | 18 | $367 | $20 |
| Pravastatin | 19 | $271 | $14 |
| Escitalopram | 15 | $243 | $16 |
| Lisinopril | 19 | $225 | $12 |
| Simvastatin | 12 | $177 | $15 |
| Amlodipine Besylate | 11 | $147 | $13 |
| Sertraline | 12 | $64 | $5 |
2021: 8 drugs
| Promethazine | 15 | $775 | $52 |
| Gabapentin | 12 | $308 | $26 |
| Atorvastatin | 12 | $161 | $13 |
| Simvastatin | 13 | $145 | $11 |
| Amlodipine Besylate | 16 | $122 | $8 |
| Lisinopril | 21 | $113 | $5 |
| Escitalopram | 11 | $103 | $9 |
| Losartan | 12 | $55 | $5 |
2019: 1 drug
| Amlodipine Besylate | 11 | $125 | $11 |
2018: 22 drugs
| Eliquis | 20 | $11,782 | $589 |
| Symbicort | 11 | $3,676 | $334 |
| Atorvastatin | 49 | $1,200 | $24 |
| Levothyroxine | 45 | $1,156 | $26 |
| Metoprolol | 31 | $876 | $28 |
| Fluoxetine | 17 | $791 | $47 |
| Gabapentin | 31 | $606 | $20 |
| Oxycodone | 13 | $478 | $37 |
| Omeprazole | 62 | $472 | $8 |
| Simvastatin | 44 | $421 | $10 |
| Lisinopril | 53 | $402 | $8 |
| Rosuvastatin | 21 | $363 | $17 |
| Metformin | 25 | $248 | $10 |
| Tamsulosin | 12 | $228 | $19 |
| Losartan | 21 | $221 | $11 |
| Amlodipine Besylate | 41 | $203 | $5 |
| Alendronate | 12 | $156 | $13 |
| Atenolol | 12 | $134 | $11 |
| Fluticasone Propionate | 11 | $127 | $12 |
| Sertraline | 13 | $99 | $8 |
| Hydrochlorothiazide | 15 | $64 | $4 |
| Furosemide | 11 | $43 | $4 |
2017: 38 drugs
| Lantus Solostar | 13 | $12,580 | $968 |
| Lyrica | 22 | $10,593 | $482 |
| Eliquis | 16 | $9,041 | $565 |
| Symbicort | 17 | $5,845 | $344 |
| Levothyroxine | 62 | $1,806 | $29 |
| Fluoxetine | 18 | $1,704 | $95 |
| Potassium Chloride | 29 | $1,651 | $57 |
| Metoprolol | 44 | $1,200 | $27 |
| Oxycodone | 32 | $972 | $30 |
| Atorvastatin | 44 | $959 | $22 |
| Valsartan | 16 | $805 | $50 |
| Omeprazole | 83 | $797 | $10 |
| Methadone | 11 | $723 | $66 |
| Enalapril Maleate | 15 | $670 | $45 |
| Lisinopril | 94 | $665 | $7 |
| Tizanidine | 20 | $659 | $33 |
| Gabapentin | 26 | $571 | $22 |
| Simvastatin | 72 | $511 | $7 |
| Tamsulosin | 17 | $456 | $27 |
| Bisoprolol | 12 | $402 | $34 |
| Amlodipine Besylate | 52 | $395 | $8 |
| Isosorbide Mononitrate Er | 17 | $392 | $23 |
| Fluticasone Propionate | 27 | $389 | $14 |
| Metformin | 32 | $353 | $11 |
| Hydrochlorothiazide | 41 | $322 | $8 |
| Alendronate | 24 | $206 | $9 |
| Losartan | 16 | $200 | $12 |
| Montelukast | 13 | $195 | $15 |
| Triamterene-Hydrochlorothiazid | 13 | $144 | $11 |
| Atenolol | 20 | $143 | $7 |
| Ranitidine | 21 | $143 | $7 |
| Trazodone | 12 | $124 | $10 |
| Lamotrigine | 11 | $89 | $8 |
| Glipizide | 17 | $84 | $5 |
| Ibuprofen | 12 | $80 | $7 |
| Lorazepam | 15 | $71 | $5 |
| Furosemide | 26 | $71 | $3 |
| Tramadol | 13 | $57 | $4 |
2016: 34 drugs
| Lyrica | 29 | $16,029 | $553 |
| Lantus Solostar | 14 | $9,130 | $652 |
| Symbicort | 13 | $4,887 | $376 |
| Xarelto | 11 | $3,885 | $353 |
| Levothyroxine | 60 | $1,718 | $29 |
| Metoprolol | 46 | $1,448 | $31 |
| Fluoxetine | 19 | $1,326 | $70 |
| Valsartan | 24 | $1,181 | $49 |
| Oxycodone | 37 | $964 | $26 |
| Omeprazole | 82 | $871 | $11 |
| Potassium Chloride | 13 | $846 | $65 |
| Atorvastatin | 42 | $824 | $20 |
| Proair Hfa | 11 | $812 | $74 |
| Isosorbide Mononitrate Er | 15 | $804 | $54 |
| Ventolin Hfa | 14 | $783 | $56 |
| Enalapril Maleate | 16 | $698 | $44 |
| Amlodipine Besylate | 65 | $632 | $10 |
| Simvastatin | 87 | $601 | $7 |
| Lisinopril | 90 | $585 | $7 |
| Tizanidine | 17 | $579 | $34 |
| Gabapentin | 16 | $468 | $29 |
| Morphine Sulfate Er | 13 | $460 | $35 |
| Metformin | 50 | $412 | $8 |
| Bisoprolol | 11 | $367 | $33 |
| Hydrochlorothiazide | 41 | $344 | $8 |
| Fluticasone Propionate | 27 | $236 | $9 |
| Losartan | 18 | $210 | $12 |
| Alendronate | 22 | $199 | $9 |
| Glipizide | 16 | $123 | $8 |
| Atenolol | 15 | $103 | $7 |
| Citalopram Hbr | 13 | $85 | $7 |
| Naproxen | 11 | $78 | $7 |
| Furosemide | 27 | $75 | $3 |
| Ranitidine | 11 | $70 | $6 |
2015: 30 drugs
| Lantus Solostar | 13 | $7,529 | $579 |
| Spiriva | 14 | $6,762 | $483 |
| Advair Diskus | 11 | $3,803 | $346 |
| Crestor | 14 | $3,771 | $269 |
| Metoprolol | 43 | $1,711 | $40 |
| Fluoxetine | 15 | $1,283 | $86 |
| Valsartan | 17 | $1,168 | $69 |
| Atorvastatin | 28 | $1,123 | $40 |
| Oxycodone | 30 | $1,092 | $36 |
| Omeprazole | 74 | $932 | $13 |
| Proair Hfa | 16 | $924 | $58 |
| Morphine Sulfate Er | 19 | $849 | $45 |
| Levothyroxine | 23 | $529 | $23 |
| Gabapentin | 23 | $519 | $23 |
| Lisinopril | 65 | $456 | $7 |
| Amlodipine Besylate | 52 | $452 | $9 |
| Simvastatin | 62 | $428 | $7 |
| Fluticasone Propionate | 30 | $319 | $11 |
| Hydrochlorothiazide | 38 | $318 | $8 |
| Metformin | 18 | $202 | $11 |
| Isosorbide Mononitrate Er | 16 | $172 | $11 |
| Alendronate | 14 | $154 | $11 |
| Atenolol | 23 | $152 | $7 |
| Prednisone | 12 | $129 | $11 |
| Naproxen | 16 | $117 | $7 |
| Furosemide | 35 | $113 | $3 |
| Losartan | 14 | $101 | $7 |
| Tramadol | 19 | $80 | $4 |
| Alcohol Swabs | 13 | $70 | $5 |
| Glipizide | 20 | $62 | $3 |
2014: 23 drugs
| Wellbutrin Xl | 11 | $14,753 | $1,341 |
| Spiriva | 12 | $5,234 | $436 |
| Lyrica | 13 | $4,721 | $363 |
| Diovan | 12 | $4,214 | $351 |
| Crestor | 13 | $3,194 | $246 |
| Metoprolol | 32 | $1,668 | $52 |
| Oxycodone | 22 | $1,079 | $49 |
| Proair Hfa | 12 | $992 | $83 |
| Omeprazole | 62 | $772 | $12 |
| Atorvastatin | 12 | $762 | $63 |
| Simvastatin | 46 | $639 | $14 |
| Methadone | 12 | $441 | $37 |
| Lisinopril | 49 | $423 | $9 |
| Isosorbide Mononitrate Er | 13 | $396 | $30 |
| Tamsulosin | 26 | $374 | $14 |
| Fluticasone Propionate | 21 | $351 | $17 |
| Amlodipine Besylate | 27 | $348 | $13 |
| Levothyroxine | 17 | $293 | $17 |
| Metformin | 26 | $261 | $10 |
| Hydrochlorothiazide | 41 | $232 | $6 |
| Atenolol | 18 | $185 | $10 |
| Furosemide | 31 | $116 | $4 |
| Fluoxetine | 11 | $90 | $8 |
2013: 13 drugs
| Wellbutrin Xl | 12 | $10,049 | $837 |
| Advair Diskus | 14 | $5,514 | $394 |
| Atorvastatin | 28 | $1,368 | $49 |
| Metoprolol | 20 | $988 | $49 |
| Simvastatin | 37 | $726 | $20 |
| Omeprazole | 34 | $560 | $16 |
| Lisinopril | 41 | $354 | $9 |
| Amlodipine Besylate | 18 | $307 | $17 |
| Hydrochlorothiazide | 31 | $298 | $10 |
| Atenolol | 24 | $214 | $9 |
| Levothyroxine | 15 | $158 | $11 |
| Furosemide | 15 | $79 | $5 |
| Prednisone | 12 | $66 | $5 |
Professional record
- NPI
- 1770633661
- Licence
- MA 235236
- Trained
- Harvard Medical School, 2005 · 21 years ago
- Group
- University of California San Francisco · University of California Sfgh Medical Group
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 1545 Divisadero St, San Francisco, CA, 94143
- NPI first listed
- 2007-01-11
- NPI last updated
- 2021-11-18
- NPI record certified
- 2021-11-18
This is when the NPI record was last certified, not a medical board exam.